The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 will need to undergo substantial clinical trials with their physician or primary care provider before being approved to receive the vaccination.